Physician profile
Sumit Dewanjee
NPI 1831153600
$9,529.05
in general payments reported to CMS, 2019-2025
36 companies · $970 in 2025
The $970 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $934 · 2020: $183 · 2021: $1,982 · 2022: $2,186 · 2023: $3,033 · 2024: $241 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,797 · Travel and Lodging: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,797.39 |
| Travel and Lodging | $1,446.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impactortho, INC. | $1,706.98 | 2022-2025 | |
| Stryker Corporation | $1,402.03 | 2020-2025 | Mako, Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid |
| Arthrex, INC. | $1,056.06 | 2023 | |
| Conformis, INC. | $912.66 | 2019-2021 | |
| Abbott Laboratories | $637.85 | 2021-2025 | Proclaim |
| Smith+Nephew, INC. | $636.45 | 2020-2025 | Evos, Evos Mini, N/A |
| Zimmer Biomet Holdings, INC. | $405.37 | 2020-2023 | Oss Orthopedic Salvage System |
| Catalyst Orthoscience | $373.39 | 2021 | |
| Anika Therapeutics, INC. | $371.38 | 2020-2025 | Revomotion, Integrity Implant |
| Team_makena_llc | $225.38 | 2019-2021 | |
| Osteomed LLC | $214.54 | 2021 | |
| Djo, LLC | $202.85 | 2020-2025 | Cmf |
| Curonix LLC | $195.62 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Aap Implants INC | $167.57 | 2021-2022 | |
| Arthrosurface Incorporated | $99.30 | 2019 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biom'Up Sa | $98.79 | 2019 | |
| Next Science LLC | $94.62 | 2025 | Blastx, Xperience |
| Kowa Pharmaceuticals America, INC. | $93.43 | 2022-2023 | Seglentis |
| Flower Orthopedics Coporation | $68.84 | 2025 | |
| Bioventus LLC | $57.58 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $53.60 | 2022-2025 | Anthem |
| Depuy Synthes Sales INC. | $52.90 | 2022 | |
| Onkos Surgical, INC. | $48.61 | 2025 | Eleos Limb Salvage System |
| Electronic Waveform Lab, INC. | $43.63 | 2022 | |
| Heron Therapeutics, INC. | $40.46 | 2021 | |
| Innocoll Pharmaceuticals Limited | $38.58 | 2021 | |
| Orthofix Medical, INC. | $35.60 | 2019-2021 | |
| Illuminoss Medical, INC. | $31.37 | 2022 | |
| Stimlabs LLC | $29.05 | 2025 | Corplex P |
| Davol INC. | $27.66 | 2020-2022 | |
| Moximed, INC | $23.62 | 2025 | Misha Knee System, Small, Left |
| Lifenet Health | $23.05 | 2023 | |
| Ethicon US, LLC | $18.91 | 2022 | |
| Avanos Medical | $17.57 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Vericel Corporation | $13.75 | 2025 | Maci |
| X-Spine Systems, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Dewanjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.